{"topic_id":"evidence_canine_epilepsy_mct_diet","category":"evidence","context":"---\ntopic_id: evidence_canine_epilepsy_mct_diet\ncategory: evidence\ntitle: Evidence cluster — medium-chain triglyceride / ketogenic diets in canine epilepsy (peer-reviewed, Europe PMC + PubMed)\nlang: en\nsource_file: pdf-raw/evidence/europepmc_canine_epilepsy_mct_diet_2026-07-22.txt\nsource: Europe PMC REST search (first-hand PMIDs) + PubMed efetch verbatim abstracts, pulled 2026-07-22\ndate_parsed: 2026-07-22\nmodel: codebuddy\nbatch: P0-EVIDENCE-6\nverified: true\npath: evidence/evidence_canine_epilepsy_mct_diet/01_canine_epilepsy_mct_diet.md\nsource_document: \"Veterinary / medical evidence (guideline or study) — PMID 42280378\"\ncitation:\n  authority: \"Europe PMC\"\n  title: \"Evidence cluster — medium-chain triglyceride / ketogenic diets in canine epilepsy (peer-reviewed, Europe PMC + PubMed)\"\n  url: \"https://pubmed.ncbi.nlm.nih.gov/42280378/\"\n  retrieved: \"2026-07-22\"\n  ref: \"PMID 42280378\"\n  doc_type: \"official PDF\"\n  needs_review: false\ncopyright_note: \"Mixed licensing per COPYRIGHT_POLICY §3: Open Access (CC BY) studies retained verbatim with attribution; non-Open-Access studies paraphrased as derived fact summaries (numbers and proper nouns preserved, sentences rewritten).\"\nverification:\n  method: paraphrase\n  claims: 5\n  passed: 5\nlicense: mixed\nauthority_tier: T2\nauthority_tier_basis: \"T2:oa-repo\"\nauthority_tier_date: 2026-08-04\n---\n# evidence_canine_epilepsy_mct_diet\n\nSource: first-hand peer-reviewed abstracts (Europe PMC / PubMed efetch), reproduced verbatim. Each claim below is a C1 substring of the cited source file.\n\n## Claims (C1 — verbatim substrings of source_file)\n\n1. PMID 42280378 — Canine Idiopathic Epilepsy as a Natural Animal Model for Human Epilepsy: A Scoping Review Highlighting Metabolic Perspectives Beyond the Brain (Nutrients, 2026). Abstract (opening): Background: Emerging evidence indicates that epilepsy extends beyond the brain, involving systemic metabolic, immune, and microbiome perturbations that shape neuronal excitability and treatment response. Canine idiopathic epilepsy (CE) offers a naturally occurring model with strong electrophysiological, pharmacological, and clinical homology to human epilepsies. *[CC BY — Open Access, verbatim with attribution.]*\n2. PMID 40170936 — *[Paraphrased derived summary — non-Open-Access source.]* A canine case study (the TREAT protocol) described alimentary (dietary) therapy for treatment-refractory epilepsy; the authors note that ~30–40% of idiopathic epilepsy cases in both humans and dogs remain refractory to antiepileptic medications, motivating dietary approaches. (Source excerpt truncated at abstract opening.)\n3. PMID 40004205 — Exploring Gut Microbiota-Targeted Therapies for Canine Idiopathic Epilepsy (Int J Mol Sci, 2025). Abstract (opening): Epilepsy stands out as one of the most prevalent chronic neurological conditions affecting companion animals. Recent research has increasingly focused on exploring the role of gut microbiota in influencing neurological conditions, like epilepsy. *[CC BY — Open Access, verbatim with attribution.]*\n4. PMID 42311395 — A multicenter retrospective analysis of canine idiopathic epilepsy in China (Front Vet Sci, 2026). Abstract (opening): OBJECTIVE: Canine idiopathic epilepsy (IE) is one of the most common neurological diseases in veterinary medicine, with no comprehensive study in China. This study collected IE cases from five large referral pet hospitals and conducted a multicenter retrospective analysis in order to supplement the clinical data of canine IE in China, clarify the predisposing factors, diagnostic and therapeutic characteristics of canine IE in the China, and provide regional clinical data for cross-country comparison of canine epilepsy diagnosis and treatment. *[CC BY — Open Access, verbatim with attribution.]*\n5. PMID 38783265 — Re-evaluating the placebo response in recent canine dietary epilepsy trials (BMC Vet Res, 2024). Abstract (opening): The placebo response is a common phenomenon. Limited evidence is available about its magnitude in canine epilepsy trials, even though it can significantly influence the efficacy evaluation of new treatments. *[CC BY — Open Access, verbatim with attribution.]*\n\nSource: `pdf-raw/evidence/europepmc_canine_epilepsy_mct_diet_2026-07-22.txt`\n\n## License & attribution\n\nMixed licensing per COPYRIGHT_POLICY §3: Open Access (CC BY / CC BY-NC /\nCC BY-NC-ND) studies are reproduced verbatim with attribution under their specific\nCC license; non-Open-Access studies are paraphrased as derived fact summaries\n(numbers and proper nouns preserved, sentences rewritten). Original records:\n- https://pubmed.ncbi.nlm.nih.gov/42280378/\n- https://pubmed.ncbi.nlm.nih.gov/40170936/\n- https://pubmed.ncbi.nlm.nih.gov/40004205/\n- https://pubmed.ncbi.nlm.nih.gov/42311395/\n- https://pubmed.ncbi.nlm.nih.gov/38783265/\n\n## Cleaning removal log (2026-08-05, codebuddy)\nPMID 42410958 — Self-labeled Off-topic: phenobarbital P450 oxidative-metabolism pharmacokinetics in dogs, not MCT/ketogenic dietary therapy — mis-clustered into this topic.\n","sources":["Europe PMC — Evidence cluster — medium-chain triglyceride / ketogenic diets in canine epilepsy (peer-reviewed, Europe PMC + PubMed) (retrieved 2026-07-22)"],"source":{"authority":"Europe PMC","title":"Evidence cluster — medium-chain triglyceride / ketogenic diets in canine epilepsy (peer-reviewed, Europe PMC + PubMed)","url":"https://pubmed.ncbi.nlm.nih.gov/42280378/","retrieved":"2026-07-22","ref":"PMID 42280378","doc_type":"official PDF","source_document":"Veterinary / medical evidence (guideline or study) — PMID 42280378","verification_file":"pdf-raw/evidence/europepmc_canine_epilepsy_mct_diet_2026-07-22.txt"},"source_document":"Veterinary / medical evidence (guideline or study) — PMID 42280378","source_file":"pdf-raw/evidence/europepmc_canine_epilepsy_mct_diet_2026-07-22.txt","trust":{"authority_tier":"T2","fidelity":"paraphrase","license":"mixed","display_grade":"B"},"tokens_estimated":796,"generated_at":null,"tip":"Use /api/v1/topics to discover more topics. /api/v1/nutrient for precise single-point queries. /api/v1/cross_compare for 2-3 standard comparisons."}